Prostaxen (Apalutamide) Tablets

Indicated for the treatment of adult men with:

• 🔹 Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC): Patients whose cancer no longer responds to medical or surgical treatment that lowers testosterone but has not yet spread to other parts of the body.
• 🔹 Metastatic Castration-Sensitive Prostate Cancer (mCSPC): Cancer that has spread to other parts of the body and still responds to treatment that lowers testosterone.

Packaging: 60 mg tablets.

⚠️ ADMINISTRATION PROTOCOL:

• Recommended Dose: 240 mg administered orally once daily.
• Pill Count: Taking 4 tablets of 60 mg at the same time.
• Timing: Take once daily, at approximately the same time each day.
• Administration: Swallow tablets whole. Can be taken with or without food.
• Missed Dose: If a dose is missed, take it as soon as possible on the same day. Resume normal schedule the next day. Do not take extra tablets to make up the missed dose.

• Hypersensitivity to Apalutamide.
• Women (specifically pregnant or breastfeeding women).
• History of seizures (use with caution).
• Severe renal or hepatic impairment.

Common adverse reactions include:

• 🩸 Physical: Severe fatigue, hot flushes, weight loss.
• 📉 Dermatologic: Skin rash (maculopapular), itching.
• 🌀 Risks: Hypertension, increased risk of falls and fractures.
• ⚠️ Monitoring: Thyroid function should be monitored as hypothyroidism can occur.